Vol. 10 No. 1 (2021): January-December 2021

Published: 2021-12-28

Full Issue

Vol. 10 January-December 2021

Review

Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?

Stefan Erfurt, Meike Hoffmeister, Stefanie Oess, Katharina Asmus, Oliver Ritter, Susann Patschan, Daniel Patschan

20-25

DOI: https://doi.org/10.33393/jcb.2021.2327
- PDF
- ePub
- html

Original research article

Value of clinical laboratory test for early prediction of mortality in patients with COVID-19: the BGM score

Laura Macías-Muñoz, Robin Wijngaard, Bernardino González-de la Presa, Jose Luis Bedini, Manuel Morales-Ruiz, Wladimiro Jiménez

1-8

DOI: https://doi.org/10.33393/jcb.2021.2194
- PDF
- ePub
- html
- Supplementary material
Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring

Vittoria Barchiesi, Vittorio Simeon, Claudia Sandomenico, Monica Cantile, Dionigio Cerasuolo, Paolo Chiodini, Alessandro Morabito, Ernesta Cavalcanti

9-13

DOI: https://doi.org/10.33393/jcb.2021.2212
- PDF
- ePub
- html
Pharmacokinetics of the disialoganglioside, GD2, a circulating tumor biomarker for neuroblastoma, in nonhuman primates

Frank M. Balis, Cynthia Lester McCully, Christine M. Busch, Elizabeth Fox, Katherine E. Warren

26-29

DOI: https://doi.org/10.33393/jcb.2021.2329
- PDF
- ePub
- html

Short communication

Circulating erythroblast abnormality associated with systemic pathologies may indicate bone marrow damage

Stefan Schreier, Prapaphan Budchart, Suparerk Borwornpinyo, Wichit Arpornwirat, Wannapong Triampo

14-19

DOI: https://doi.org/10.33393/jcb.2021.2220
- PDF
- ePub
- html